RGNX

REGENXBIO INC

Healthcare | Small Cap

-$1.35

EPS Forecast

$23.53

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.35

Revenue Forecast:

$23.53

EPS Surprise Forecast:

$0.004

Revenue Surprise Forecast:

-$0

Post-release price volatility - Very high

Post-release Overnight Move:

±10.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

52%

Probability of beating revenue consensus:

48%

Probability of beating both EPS & revs consensus:

31%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.37

Revenue standard deviation:

$8

As % of share price:

4.48% EXTREME UNCERTAINTY

As % of market cap:

1.80% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.90

Revenue 95th %ile:

$33

EPS 75th %ile:

-$1.23

Revenue 75th %ile:

$26

EPS 25th %ile:

-$1.46

Revenue 25th %ile:

$21

EPS 5th %ile:

-$1.81

Revenue 5th %ile:

$16

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

92% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$36

Bid-ask per Share:

$0.03